Gender differences in long‐term outcome after primary percutaneous intervention for ST‐segment elevation myocardial infarction
- 29 April 2013
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 82 (3), 379-384
- https://doi.org/10.1002/ccd.24800
Abstract
Background Previous studies on gender differences in outcome in patients with ST segment elevation myocardial infarction (STEMI) have been performed, but most of those are from before the current era of PCI technique and medical therapy and have a short duration of follow‐up. The objective of our study is to assess the influence of gender on long‐term outcome in patients with STEMI who underwent primary percutaneous intervention (PCI) between January 2006 and May 2008. Methods Two‐year follow‐up data from 202 female and 668 male patients undergoing primary PCI for STEMI were available from the DEBATER (A Comparison of Drug Eluting and Bare Metal Stents for Primary Percutaneous Coronary Intervention with or without Abciximab in ST‐segment elevation Myocardial Infarction: The Eindhoven Reperfusion Study) trial database. The primary endpoint was major adverse cardiac events (MACE), defined as the composite of death, myocardial infarction, and target vessel revascularization. Results Women were older (64.7 ± 11.7 vs. 59.0 ± 10.7; P < 0.001), and had more often diabetes mellitus (15% vs. 9%; P = 0.01) and hypertension (44% vs. 25%; P < 0.001). At two years, the rate of MACE was significantly higher in women (21% vs. 14%; P = 0.02). The mortality rate in women was 8% versus 2.6% in men (P < 0.001). However, multivariate analysis after adjustment for age and the baseline characteristics hypertension, smoking, diabetes mellitus, stent diameter, and time between onset of symptoms and arrival of the ambulance showed similar MACE and mortality rates in men and women. Conclusion Women have higher rates of both MACE and mortality after primary PCI for STEMI compared to men because of higher age with higher baseline risk profiles.Keywords
This publication has 31 references indexed in Scilit:
- Comparison of Drug-Eluting and Bare-Metal Stents for Primary Percutaneous Coronary Intervention With or Without Abciximab in ST-Segment Elevation Myocardial Infarction: DEBATER: The Eindhoven Reperfusion StudyJACC: Cardiovascular Interventions, 2012
- Female gender is an independent predictor of in-hospital mortality after STEMI in the era of primary PCI: insights from the greater Paris area PCI RegistryEuroIntervention, 2011
- Gender-related differences in mortality after ST-segment elevation myocardial infarction: a large multicentre national registryEuroIntervention, 2011
- Gender outcomes in acute myocardial infarction: are women from Venus and men from Mars?EuroIntervention, 2011
- Gender-related difference in ST-elevation myocardial infarction treated with primary angioplasty: a single-centre 6-year registryEuropean Journal of Preventive Cardiology, 2011
- Comparison of Mortality Rates in Women Versus Men Presenting With ST-Segment Elevation Myocardial InfarctionThe American Journal of Cardiology, 2011
- The association of sex with outcomes among patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction in the contemporary era: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)American Heart Journal, 2010
- Gender perspective on risk factors, coronary lesions and long-term outcome in young patients with ST-elevation myocardial infarctionHeart, 2010
- Short- and Long-Term Prognosis After Acute Myocardial Infarction in Men Versus WomenThe American Journal of Cardiology, 2006
- Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseasesEuropean Heart Journal, 2005